| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |